Gursel Aktan

11.1k citations
52 papers · 3.1k indexed · 1 hit paper · h-index 22
Topics
Cancer Immunotherapy and Biomarkers (21 papers)Cancer Treatment and Pharmacology (15 papers)Advanced Breast Cancer Therapies (14 papers)

In The Last Decade

Gursel Aktan

52 papers receiving 3.0k citations

Hit Papers

Pembrolizumab in Patients With Advanced Triple-Negative B...201620262019202220162505007501000

Peers

Gursel Aktan
Comparison fields: 5 of 86
  • Oncology 2.5k
  • Pulmonary and Respiratory Medicine 858
  • Cancer Research 787
  • Immunology 740
  • Molecular Biology 563
Replace Gail S. Wright with:
Gail S. Wright United States
Andreas Schneeweiss United States
Marleen Kok Netherlands
Jennifer R. Diamond United States
Valentina Boni Spain
Kevin Kalinsky United States
Maria Vittoria Dieci Italy
Debora Fumagalli Belgium
Giorgio Valabrega Italy
Virginia McNally United Kingdom
Gursel Aktan relative to Gail S. Wright United States Gail S. Wright's profile →
Citations per field
00.5×12.1×
Gail S. Wright · 1×
Citations per year

Countries citing papers authored by Gursel Aktan

Since Specialization
Citations

This map shows the geographic impact of Gursel Aktan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gursel Aktan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gursel Aktan more than expected).

Fields of papers citing papers by Gursel Aktan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gursel Aktan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gursel Aktan. The network helps show where Gursel Aktan may publish in the future.

Co-authorship network of co-authors of Gursel Aktan

This figure shows the co-authorship network connecting the top 25 collaborators of Gursel Aktan. A scholar is included among the top collaborators of Gursel Aktan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gursel Aktan. Gursel Aktan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 1
3 1
4 1
5 2
6 90
7 10
8 89
9 7
10 17
11 5
12 8
13 68
14 5
15 5
16 3
17 9
18
A STUDY OF THE EFFECTS OF INHIBITION OF CYP3A4 BY KETOCONAZOLE (K) AND CYP2C8 BY GEMFIBROZIL (G) ON THE PHARMACOKINETICS DABRAFENIB (D)
3
19 41
20 100

About Gursel Aktan

Gursel Aktan is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Cancer Treatment and Pharmacology (15 papers) and Advanced Breast Cancer Therapies (14 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (787 citations) and Immunology (740 citations). Gursel Aktan has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Vassiliki Karantza, Lajos Pusztai, Shilpa Gupta, Elizabeth Claire Dees, Raanan Berger, Laura Q.M. Chow, Kumudu Pathiraja, Ravit Geva, Rita Nanda and Laurence Buisseret. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026